CAI logo

Caris Life Sciences, Inc. (CAI) EBIT

annual EBIT:

-$231.87M+$77.94M(+25.16%)
December 1, 2024

Summary

  • As of today (August 26, 2025), CAI annual earnings before interest & taxes is -$231.87 million, with the most recent change of +$77.94 million (+25.16%) on December 1, 2024.
  • During the last 3 years, CAI annual EBIT has risen by +$62.28 million (+21.17%).
  • CAI annual EBIT is now -255.22% below its all-time high of $149.38 million, reached on December 1, 2018.

Performance

CAI EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCAIincome statement metrics

quarterly EBIT:

-$17.99M+$39.96M(+68.96%)
June 1, 2025

Summary

  • As of today (August 26, 2025), CAI quarterly earnings before interest & taxes is -$17.99 million, with the most recent change of +$39.96 million (+68.96%) on June 1, 2025.
  • Over the past year, CAI quarterly EBIT has increased by +$48.20 million (+72.82%).
  • CAI quarterly EBIT is now -143.04% below its all-time high of $41.79 million, reached on September 30, 2021.

Performance

CAI quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCAIincome statement metrics

TTM EBIT:

-$75.94M+$48.20M(+38.83%)
June 1, 2025

Summary

  • As of today (August 26, 2025), CAI TTM earnings before interest & taxes is -$75.94 million, with the most recent change of +$48.20 million (+38.83%) on June 1, 2025.
  • Over the past year, CAI TTM EBIT has increased by +$82.47 million (+52.06%).
  • CAI TTM EBIT is now -156.04% below its all-time high of $135.51 million, reached on September 30, 2021.

Performance

CAI TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCAIincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CAI EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.2%+72.8%+52.1%
3 y3 years+21.2%+80.5%+17.7%
5 y5 years-266.4%-219.9%-236.6%

CAI EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-261.2%+25.2%-143.0%+80.5%-156.0%+52.1%
5 y5-year-261.2%+25.2%-143.0%+80.5%-156.0%+52.1%
alltimeall time-255.2%+25.2%-143.0%+80.5%-156.0%+52.1%

CAI EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$17.99M(-69.0%)
-$75.94M(-38.8%)
Mar 2025
-
-$57.95M(-12.4%)
-$124.14M(-21.6%)
Dec 2024
-$231.87M(-25.2%)
-
-
Jun 2024
-
-$66.19M(-28.2%)
-$158.41M(+71.8%)
Mar 2024
-
-$92.22M(-320.7%)
-$92.22M(-168.1%)
Dec 2023
-$309.81M(+5.3%)
-
-
Dec 2022
-$294.15M(-304.5%)
-
-
Sep 2021
-
$41.79M(+27.8%)
$135.51M(+19.3%)
Jun 2021
-
$32.70M(+6.0%)
$113.60M(+18.5%)
Mar 2021
-
$30.85M(+2.2%)
$95.90M(+23.7%)
Dec 2020
$143.81M(+3.2%)
$30.17M(+51.8%)
$77.52M(+23.9%)
Sep 2020
-
$19.88M(+32.5%)
$62.58M(+12.6%)
Jun 2020
-
$15.00M(+20.3%)
$55.58M(+1.0%)
Mar 2020
-
$12.47M(-18.2%)
$55.05M(+1.9%)
Dec 2019
$139.30M(-6.7%)
-
-
Dec 2019
-
$15.23M(+18.4%)
$54.02M(-9.0%)
Sep 2019
-
$12.87M(-11.1%)
$59.39M(-12.3%)
Jun 2019
-
$14.47M(+26.5%)
$67.72M(-6.6%)
Mar 2019
-
$11.44M(-44.5%)
$72.52M(-5.5%)
Dec 2018
$149.38M(+52.9%)
$20.61M(-2.8%)
$76.70M(+4.7%)
Sep 2018
-
$21.20M(+10.1%)
$73.24M(+7.2%)
Jun 2018
-
$19.27M(+23.3%)
$68.30M(+14.3%)
Mar 2018
-
$15.62M(-8.9%)
$59.77M(+18.5%)
Dec 2017
$97.69M(+85.6%)
$17.14M(+5.4%)
$50.43M(+45.4%)
Sep 2017
-
$16.27M(+51.6%)
$34.68M(+133.3%)
Jun 2017
-
$10.73M(+71.0%)
$14.86M(+77.0%)
Mar 2017
-
$6.28M(+351.4%)
$8.40M(-20.3%)
Dec 2016
$52.63M(-21.7%)
$1.39M(-139.3%)
$10.53M(-51.7%)
Sep 2016
-
-$3.54M(-183.0%)
$21.80M(-44.9%)
Jun 2016
-
$4.27M(-49.3%)
$39.56M(-19.9%)
Mar 2016
-
$8.41M(-33.5%)
$49.38M(-11.0%)
Dec 2015
$67.26M(-34.6%)
$12.66M(-11.0%)
$55.48M(+96.0%)
Sep 2015
-
$14.22M(+0.9%)
$28.30M(-31.4%)
Jun 2015
-
$14.09M(-2.9%)
$41.26M(-19.9%)
Mar 2015
-
$14.52M(-200.0%)
$51.52M(-16.1%)
Dec 2014
$102.78M
-$14.52M(-153.4%)
$61.44M(+1.4%)
DateAnnualQuarterlyTTM
Sep 2014
-
$27.18M(+11.6%)
$60.58M(+1.6%)
Jun 2014
-
$24.34M(-0.4%)
$59.60M(-5.5%)
Mar 2014
-
$24.43M(-258.9%)
$63.10M(-3.5%)
Dec 2013
$107.58M(+4.6%)
-$15.38M(-158.7%)
$65.41M(-40.7%)
Sep 2013
-
$26.20M(-5.9%)
$110.38M(+0.1%)
Jun 2013
-
$27.84M(+4.1%)
$110.22M(+3.3%)
Mar 2013
-
$26.74M(-9.6%)
$106.74M(+3.7%)
Dec 2012
$102.89M(+31.9%)
$29.59M(+13.6%)
$102.89M(+9.2%)
Sep 2012
-
$26.05M(+6.9%)
$94.22M(+4.8%)
Jun 2012
-
$24.36M(+6.4%)
$89.86M(+9.0%)
Mar 2012
-
$22.90M(+9.5%)
$82.42M(+5.6%)
Dec 2011
$78.04M(+110.7%)
$20.91M(-3.6%)
$78.04M(+8.9%)
Sep 2011
-
$21.69M(+28.2%)
$71.68M(+19.2%)
Jun 2011
-
$16.92M(-8.6%)
$60.12M(+18.3%)
Mar 2011
-
$18.52M(+27.3%)
$50.81M(+37.2%)
Dec 2010
$37.03M(+70.0%)
$14.55M(+43.6%)
$37.03M(+37.3%)
Sep 2010
-
$10.13M(+33.2%)
$26.96M(+23.8%)
Jun 2010
-
$7.61M(+60.3%)
$21.78M(+10.7%)
Mar 2010
-
$4.75M(+6.0%)
$19.68M(-9.7%)
Dec 2009
$21.79M(-459.5%)
$4.48M(-9.5%)
$21.79M(-201.8%)
Sep 2009
-
$4.95M(-10.1%)
-$21.41M(+43.8%)
Jun 2009
-
$5.51M(-19.6%)
-$14.89M(+66.1%)
Mar 2009
-
$6.85M(-117.7%)
-$8.97M(+48.0%)
Dec 2008
-$6.06M(-115.2%)
-$38.71M(-437.6%)
-$6.06M(-113.6%)
Sep 2008
-
$11.47M(+0.3%)
$44.44M(+2.0%)
Jun 2008
-
$11.43M(+17.2%)
$43.58M(+7.2%)
Mar 2008
-
$9.76M(-17.2%)
$40.66M(+1.8%)
Dec 2007
$39.94M(+231.5%)
$11.79M(+11.2%)
$39.94M(+101.4%)
Sep 2007
-
$10.61M(+24.7%)
$19.83M(+12.3%)
Jun 2007
-
$8.51M(-5.8%)
$17.66M(+9.8%)
Mar 2007
-
$9.03M(-208.6%)
$16.07M(+128.3%)
Dec 2006
$12.05M(-50.1%)
-$8.32M(-198.6%)
$7.04M(-54.2%)
Sep 2006
-
$8.44M(+21.8%)
$15.36M(+121.8%)
Jun 2006
-
$6.92M
$6.92M
Dec 2005
$24.14M(+4.9%)
-
-
Dec 2004
$23.00M(+524.0%)
-
-
Dec 2003
$3.69M
-
-

FAQ

  • What is Caris Life Sciences, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Caris Life Sciences, Inc.?
  • What is Caris Life Sciences, Inc. annual EBIT year-on-year change?
  • What is Caris Life Sciences, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Caris Life Sciences, Inc.?
  • What is Caris Life Sciences, Inc. quarterly EBIT year-on-year change?
  • What is Caris Life Sciences, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Caris Life Sciences, Inc.?
  • What is Caris Life Sciences, Inc. TTM EBIT year-on-year change?

What is Caris Life Sciences, Inc. annual earnings before interest & taxes?

The current annual EBIT of CAI is -$231.87M

What is the all time high annual EBIT for Caris Life Sciences, Inc.?

Caris Life Sciences, Inc. all-time high annual earnings before interest & taxes is $149.38M

What is Caris Life Sciences, Inc. annual EBIT year-on-year change?

Over the past year, CAI annual earnings before interest & taxes has changed by +$77.94M (+25.16%)

What is Caris Life Sciences, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of CAI is -$17.99M

What is the all time high quarterly EBIT for Caris Life Sciences, Inc.?

Caris Life Sciences, Inc. all-time high quarterly earnings before interest & taxes is $41.79M

What is Caris Life Sciences, Inc. quarterly EBIT year-on-year change?

Over the past year, CAI quarterly earnings before interest & taxes has changed by +$48.20M (+72.82%)

What is Caris Life Sciences, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of CAI is -$75.94M

What is the all time high TTM EBIT for Caris Life Sciences, Inc.?

Caris Life Sciences, Inc. all-time high TTM earnings before interest & taxes is $135.51M

What is Caris Life Sciences, Inc. TTM EBIT year-on-year change?

Over the past year, CAI TTM earnings before interest & taxes has changed by +$82.47M (+52.06%)
On this page